What is the relationship between Adagrasib and Kai Laiying?

Adagrasib is used to treat non-small cell lung cancer in adults : Tumors that have spread to other parts of the body or cannot be removed with surgery, those with a specific genetic signature (an abnormal "KRAS G12C" gene), and those who have received at least one type of cancer treatment. Doctors will conduct tests to make sure adagrasib is the right treatment for the patient. Adagrasiib may also be used for purposes not listed in this Medication Guide. Patients should take the entire prescribed dose at consistent times each day with or without food.

Adagrasib is a specific oral inhibitor against KRAS G12C mutant, developed by Mirati. Asymchem Pharmaceutical Group (referred to as "Asymchem") published a research paper on the development of a commercial production route for adagrasib in the academic journal "Organic Process Research and Development". This research result was completed in collaboration between Asymchem’s Small Molecule Division and Mirati’s process development team. Therefore, the relationship between adagrasib and Aileen can be summarized as follows: Aileen participated in the development of the commercial production route of adagrasib and completed this research in cooperation with Mirati.

Sinceadagrasibthe original drug has not yet been launched in China, patients can only purchase adagrasib through overseas channels, and the U.S. original version of 200mg*180 tablets is priced at hundreds of thousands of yuan per box (the price may fluctuate due to exchange rates), which is very expensive. Currently, there are no generic drugs of adagrasib produced overseas. For more drug information and specific prices, please consult Yaode’s medical consultant.